Presentation Information

[1P-861]Deciphering FGFR2-IIIb/-IIIc isoform switching in advanced cancer through whole-transcriptome sequencing

○Naoko Iida1, Tadayoshi Hashimoto1,2, Takao Fujisawa1,3, Shigenori Kadowaki4, Makoto Ueno5, Shogen Boku6, Norio Nonomura7, Eiji Oki8, Yoshito Komatsu9, Akitaka Makiyama10,11, Chigusa Morizane12, Toshihiro Kudo13, Naoki Takahashi14, Taro Shibuki1,15, Mitsuho Imai1, Riu Yamashita16, Yoshiaki Nakamura1,2, Hideaki Bandou1,2, Yoshino Takayuki2 (1. Translational Research Support Office, National cancer center of Japan, East hospital, 2. Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan, 3. Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan, 4. Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan, 5. Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan, 6. Department of Clinical Oncology, Kansai Medical University Hospital, Osaka, Japan, 7. Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan, 8. Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, 9. Department of Cancer Center, Hokkaido University Hospital, Sapporo, Japan, 10. Cancer Center, Gifu University Hospital, Gifu, Japan, 11. Center for One Medicine Innovative Translational Research, Gifu University, Gifu, Japan, 12. Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan, 13. Department of Medical Oncology, Osaka International Cancer Institute Osaka Prefectural Hospital Organization, Osaka, Japan, 14. Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan, 15. Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan, 16. Division of Translational Informatics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Kashiwa, Japan)

Password required to view


Comment

To browse or post comments, you must log in.Log in